Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-HDAC6 (AA 1-180) Recombinant Antibody (18E2SC) (CBMAB-H1802-FY)

Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
18E2SC
Antibody Isotype
IgG1
Application
WB

Basic Information

Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Epitope
AA 1-180

Target

Full Name
HDAC6
Introduction
Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene belongs to class II of the histone deacetylase/acuc/apha family. It contains an internal duplication of two catalytic domains which appear to function independently of each other. This protein possesses histone deacetylase activity and represses transcription.
Entrez Gene ID
UniProt ID
Alternative Names
Histone Deacetylase 6; Protein Phosphatase 1, Regulatory Subunit 90; EC 3.5.1.98; HD6; KIAA0901; PPP1R90; CPBHM; JM21
Function
Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (PubMed:10220385).

Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (PubMed:10220385).

Histone deacetylases act via the formation of large multiprotein complexes (PubMed:10220385).

In addition to histones, deacetylates other proteins: plays a central role in microtubule-dependent cell motility by mediating deacetylation of tubulin (PubMed:12024216, PubMed:20308065).

Promotes deacetylation of CTTN, leading to actin polymerization, promotion of autophagosome-lysosome fusion and completion of autophagy (PubMed:30538141).

Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer (PubMed:24413532).

In addition to its protein deacetylase activity, plays a key role in the degradation of misfolded proteins: when misfolded proteins are too abundant to be degraded by the chaperone refolding system and the ubiquitin-proteasome, mediates the transport of misfolded proteins to a cytoplasmic juxtanuclear structure called aggresome (PubMed:17846173).

Probably acts as an adapter that recognizes polyubiquitinated misfolded proteins and target them to the aggresome, facilitating their clearance by autophagy (PubMed:17846173).
Biological Process
Aggresome assembly Source: BHF-UCL
Autophagy Source: UniProtKB-KW
Axonal transport of mitochondrion Source: ARUK-UCL
Cellular response to hydrogen peroxide Source: BHF-UCL
Cellular response to misfolded protein Source: Ensembl
Cellular response to topologically incorrect protein Source: BHF-UCL
Cilium assembly Source: Reactome
Collateral sprouting Source: Ensembl
Dendritic spine morphogenesis Source: Ensembl
Histone deacetylation Source: BHF-UCL
Hsp90 deacetylation Source: Ensembl
Intracellular protein transport Source: BHF-UCL
Lysosome localization Source: BHF-UCL
Negative regulation of hydrogen peroxide metabolic process Source: BHF-UCL
Negative regulation of microtubule depolymerization Source: Ensembl
Negative regulation of oxidoreductase activity Source: BHF-UCL
Negative regulation of protein-containing complex assembly Source: ARUK-UCL
Negative regulation of protein-containing complex disassembly Source: BHF-UCL
Negative regulation of proteolysis Source: BHF-UCL
Negative regulation of transcription, DNA-templated Source: UniProtKB
Parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization Source: ParkinsonsUK-UCL
Peptidyl-lysine deacetylation Source: BHF-UCL
Polyubiquitinated misfolded protein transport Source: BHF-UCL
Positive regulation of epithelial cell migration Source: BHF-UCL
Positive regulation of hydrogen peroxide-mediated programmed cell death Source: BHF-UCL
Positive regulation of peptidyl-serine phosphorylation Source: ARUK-UCL
Positive regulation of signaling receptor activity Source: BHF-UCL
Protein-containing complex disassembly Source: Ensembl
Protein deacetylation Source: UniProtKB
Protein destabilization Source: Ensembl
Protein polyubiquitination Source: Ensembl
Protein quality control for misfolded or incompletely synthesized proteins Source: BHF-UCL
Regulation of androgen receptor signaling pathway Source: BHF-UCL
Regulation of autophagy Source: ParkinsonsUK-UCL
Regulation of autophagy of mitochondrion Source: ParkinsonsUK-UCL
Regulation of establishment of protein localization Source: Ensembl
Regulation of fat cell differentiation Source: Ensembl
Regulation of gene expression, epigenetic Source: UniProtKB
Regulation of macroautophagy Source: BHF-UCL
Regulation of microtubule-based movement Source: BHF-UCL
Regulation of protein stability Source: ParkinsonsUK-UCL
Response to growth factor Source: BHF-UCL
Response to misfolded protein Source: BHF-UCL
Tubulin deacetylation Source: UniProtKB
Ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway Source: Ensembl
Cellular Location
Cytoplasm; Nucleus; Cytoskeleton; Perikaryon; Dendrite; Axon. It is mainly cytoplasmic, where it is associated with microtubules.
Involvement in disease
Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia (CDP-PBHM):
A disease characterized by chondrodysplasia, severe platyspondyly, hydrocephaly, and facial features with microphthalmia. Bone abnormalities include a distinctive metaphyseal cupping of the metacarpals, metatarsals, and phalanges. Affected females show a milder phenotype with small stature, sometimes associated with body asymmetry and mild mental retardation.
PTM
Phosphorylated by AURKA.
Ubiquitinated. Its polyubiquitination however does not lead to its degradation.
Sumoylated in vitro.
More Infomation

Zeleke, T. Z., Pan, Q., Chiuzan, C., Onishi, M., Li, Y., Tan, H., ... & Silva, J. (2023). Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. Nature cancer, 4(2), 257-275.

Silva, J., Yu, J., & Kalinsky, K. (2023). Reply to: Ricolinostat is not a highly selective HDAC6 inhibitor. Nature Cancer, 1-3.

Zheng, Y. C., Kang, H. Q., Wang, B., Zhu, Y. Z., Mamun, M. A. A., Zhao, L. F., ... & Gao, Y. (2023). Curriculum vitae of HDAC6 in solid tumors. International Journal of Biological Macromolecules, 123219.

Keuler, T., König, B., Bückreiß, N., Kraft, F. B., König, P., Schäker-Hübner, L., ... & Hansen, F. K. (2022). Development of the first non-hydroxamate selective HDAC6 degraders. Chemical Communications, 58(79), 11087-11090.

Pulya, S., Amin, S. A., Adhikari, N., Biswas, S., Jha, T., & Ghosh, B. (2021). HDAC6 as privileged target in drug discovery: A perspective. Pharmacological research, 163, 105274.

LoPresti, P. (2020). HDAC6 in Diseases of Cognition and of Neurons. Cells, 10(1), 12.

Auzmendi-Iriarte, J., Saenz-Antoñanzas, A., Mikelez-Alonso, I., Carrasco-Garcia, E., Tellaetxe-Abete, M., Lawrie, C. H., ... & Matheu, A. (2020). Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma. Cell death & disease, 11(6), 417.

Magupalli, V. G., Negro, R., Tian, Y., Hauenstein, A. V., Di Caprio, G., Skillern, W., ... & Wu, H. (2020). HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation. Science, 369(6510), eaas8995.

Cosenza, M., & Pozzi, S. (2018). The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease. International journal of molecular sciences, 19(8), 2337.

Wang, X. X., Wan, R. Z., & Liu, Z. P. (2018). Recent advances in the discovery of potent and selective HDAC6 inhibitors. European journal of medicinal chemistry, 143, 1406-1418.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-HDAC6 (AA 1-180) Recombinant Antibody (18E2SC)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry